Division of Hematology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskisehir, Turkey.
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Eskişehir Osmangazi University, 26480, Eskisehir, Turkey.
Rheumatol Int. 2019 Jul;39(7):1221-1228. doi: 10.1007/s00296-019-04312-w. Epub 2019 Apr 30.
Hematologic involvement or hematologic malignancies are frequently encountered during the course of rheumatic diseases. Bone marrow (BM) aspiration and/or biopsy examinations may have a diagnostic role in explaining hematologic findings detected in rheumatology clinical practice. Our aim was to describe the indications for BM examinations and to share our BM aspiration/biopsy results. We analyzed 140 BM aspiration/biopsy results of patients conducted at the Department of Rheumatology from 2010 to 2018. Demographics, complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) values, serum biochemistry test results including lactate dehydrogenase (LDH), organomegaly, indications for BM examinations and BM examination results for each patient, and mortality rates were recorded. Out of the 140 patients, 63.6% were female, and the median (Q1-Q3) age was 53 (39.5-65) years. One hundred fifteen (82.1%) patients were diagnosed as having primary rheumatic disease, and 25 (17.8%) were admitted due to musculoskeletal symptoms. Rheumatoid arthritis (RA) (n = 34, [29.5%]), and systemic lupus erythematosus (SLE) (n = 21, [18.2%]) were the most common rheumatic diseases. Cytopenia was the most common indication for BM aspiration/biopsy (n = 83, [59.3%]). Thirty-nine (47%) of 83 patients had drug-induced cytopenia. A pathology was detected in 40 (28.5%) of the 140 BM examinations. Patients with pathologic BM results had either a hematologic malignancy (n = 38, [95%]) or metastasis to a solid organ (n = 2, [5%]). The group of patients with pathologic BM biopsy results had significantly higher rates of lymphadenopathy, splenomegaly, and monoclonal gammopathy compared with the group with non-pathologic results (p = 0.001, p = 0.011, and p = 0.023, respectively). Likewise, LDH concentrations of those with pathologic results were higher than in patients with non-pathologic results [737 (range 577-1420) IU/L vs. 541 (range 306-840) IU/L, p = 0.019]. In this study, cytopenia or CBC abnormalities accompanied by elevated LDH values or anemia along with increased ESR were the most common indications for BM aspiration/biopsy. Further prospective studies are needed to determine the indications of BM aspiration/biopsy and establish the parameters that predict abnormal BM results in rheumatology practice.
在风湿性疾病的病程中,常可观察到血液学受累或血液系统恶性肿瘤。骨髓(BM)抽吸和/或活组织检查在解释风湿科临床实践中检测到的血液学发现方面可能具有诊断作用。我们的目的是描述 BM 检查的适应证,并分享我们的 BM 抽吸/活检结果。我们分析了 2010 年至 2018 年在风湿病科进行的 140 例 BM 抽吸/活检结果。记录患者的人口统计学、全血细胞计数(CBC)、红细胞沉降率(ESR)、C 反应蛋白(CRP)值、血清生化检查结果包括乳酸脱氢酶(LDH)、器官肿大、BM 检查适应证以及每位患者的 BM 检查结果和死亡率。在 140 例患者中,63.6%为女性,中位(Q1-Q3)年龄为 53(39.5-65)岁。115 例(82.1%)患者被诊断为原发性风湿病,25 例(17.8%)因肌肉骨骼症状入院。类风湿关节炎(RA)(n=34,[29.5%])和系统性红斑狼疮(SLE)(n=21,[18.2%])是最常见的风湿性疾病。细胞减少症是 BM 抽吸/活检最常见的适应证(n=83,[59.3%])。39 例(47%)的 83 例患者存在药物诱导的细胞减少症。140 例 BM 检查中有 40 例(28.5%)发现病理学变化。有病理 BM 检查结果的患者要么患有血液系统恶性肿瘤(n=38,[95%]),要么患有实体器官转移(n=2,[5%])。与无病理结果的患者相比,有病理 BM 活检结果的患者的淋巴结病、脾肿大和单克隆丙种球蛋白血症发生率显著更高(p=0.001、p=0.011 和 p=0.023)。同样,有病理结果患者的 LDH 浓度高于无病理结果患者[737(范围 577-1420)IU/L vs. 541(范围 306-840)IU/L,p=0.019]。在本研究中,细胞减少症或 CBC 异常伴有升高的 LDH 值或贫血,同时 ESR 升高,是 BM 抽吸/活检最常见的适应证。需要进一步的前瞻性研究来确定 BM 抽吸/活检的适应证,并确定预测风湿病实践中 BM 异常结果的参数。